Search Results - Sharanabasappa, S Nirni

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India

    Safety and tolerability of Peg-grafeel™, a pegfilgrastim, for the prophylactic treatment of chemotherapy-induced neutropenia and febrile neutropenia: A prospective, observational,... by Talwar, Vineet, Nirni, Sharanabasappa S., Mallavarapu, Krishna Mohan, Ramkumar, Anupama, Sinha, Nitu

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion

    Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion by Goyal, Manu, Kodandapani, Suseela, Sharanabasappa, S Nirni, Palanki, Satya Dattatreya

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Mesothelial cell inclusions mimickingadenocarcinoma in cervical lymph nodes in association with chylous effusion

    Mesothelial cell inclusions mimickingadenocarcinoma in cervical lymph nodes in association with chylous effusion by Goyal, Manu, Kodandapani, Suseela, Sharanabasappa, S Nirni, Palanki, Satya Dattatreya

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion

    Mesothelial cell inclusions mimicking adenocarcinoma in cervical lymph nodes in association with chylous effusion by Goyal, Manu, Kodandapani, Suseela, Sharanabasappa, S Nirni, Palanki, Satya Dattatreya

    Get full text
    Report
    Save to List
    Saved in:
  5. 5
    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension

    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension by Chaturvedi, Alok, Suresh, Attili Venkata Satya, Badiginchala, Revathi, Bunger, Deepak, Dattatreya, Palanki Satya, Nirni, Sharanabasappa Somanath, Andra, Vindhya Vasini

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Association of MDR1 Gene (C3435T) Polymorphism and Gene Expression Profiling in Lung Cancer Patients Treated with Platinum-Based Chemotherapy

    Association of MDR1 Gene (C3435T) Polymorphism and Gene Expression Profiling in Lung Cancer Patients Treated with Platinum-Based Chemotherapy by Subhani, Syed, Jamil, Kaiser, Nirni, Sharanabasappa Somanath

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study

    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study by Chaturvedi, Alok, Ahmad, Imran, Khan, Mujtaba Ali, Joshi, Nisarg, Somanath, Nirni Sharanabasappa, Jain, Kunal, Subramanian, Sundaram, Prasanna, Rammohan, Dattatreya, Palanki Satya, Narayanan, Prasad, Bunger, Deepak

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer

    Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer by Badiginchala, Revathi, Dattatreya, Palanki Satya, Suresh, Attili Venkata Satya, Nirni, Sharanabasappa Somanath, Andra, Vindhya Vasini, Bunger, Deepak, Chaturvedi, Alok

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma

    Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma by Kaplanov, Kamil, Zaritskiy, Andrey, Alexeev, Sergey, Volodicheva, Elena, Loginov, Alexander, Orlova, Rashida, Dvornichenko, Victoria, Kosinova, Marina, Serduk, Olga, Milovanov, Vladimir, Myasnikov, Alexander, Patil, Shekar, Rangarajan, Bharath, Rajappa, Senthil Jagannathan, Jain, Minish, Nirni, Sharanabasappa, Deka, Akhil, Rekhtman, Grigoriy B, Kryachok, Iryna, Maslyak, Zvenyslava, Chernyaeva, Ekaterina, Ivanov, Roman, Isaev, Alexander

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: